0001812479-20-000001.txt : 20200706 0001812479-20-000001.hdr.sgml : 20200706 20200706163852 ACCESSION NUMBER: 0001812479-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200706 DATE AS OF CHANGE: 20200706 EFFECTIVENESS DATE: 20200706 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Revelation Therapeutics, LLC CENTRAL INDEX KEY: 0001812479 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-370302 FILM NUMBER: 201013923 BUSINESS ADDRESS: STREET 1: 350 SHARON PARK DRIVE STREET 2: R4 CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-272-7018 MAIL ADDRESS: STREET 1: 350 SHARON PARK DRIVE STREET 2: R4 CITY: MENLO PARK STATE: CA ZIP: 94025 D 1 primary_doc.xml X0708 D LIVE 0001812479 Revelation Therapeutics, LLC 350 SHARON PARK DRIVE R4 MENLO PARK CA CALIFORNIA 94025 650-272-7018 DELAWARE None None Limited Liability Company true 2020 Chester S. Zygmont 350 Sharon Park Drive R4 Menlo Park CA CALIFORNIA 94025 Executive Officer Director James M. Rolke 350 Sharon Park Drive R4 Menlo Park CA CALIFORNIA 94025 Director George F. Tidmarsh 350 Sharon Park Drive R4 Menlo Park CA CALIFORNIA 94025 Director Biotechnology Decline to Disclose 06b false 2020-05-11 false true false 0 1001290 1001290 0 Offering consisted of 500,000 promotor shares at a purchase price of $0.001 per share, 790,000 founder shares at a purchase price of $0.001 per share and 1 seed shares at purchase price of $1.00 per share. false 10 0 0 0 false Revelation Therapeutics, LLC /s/ Chester S. Zygmont III Chester S. Zygmont III CFO 2020-07-06